https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.1076210/full
Frontiers | Astatine-211 based radionuclide therapy: Current clinical trial landscape
Astatine-211 (211At) has physical properties that make it one of the top candidates for use as a radiation source for alpha particle-based radionuclide thera...
astatine 211radionuclide therapyclinical trialfrontiersbased
https://www.ans.org/news/article-2650/researchers-report-fastest-purification-of-astatine211-needed-for-targeted-cancer-therapy/
Researchers report fastest purification of astatine-211 needed for targeted cancer therapy -- ANS /...